|
|
||||||||
Linus Pauling Institute, Oregon State University, Corvallis, Oregon 973316512
Oxidative stress has been implicated as an important etiologic factor in atherosclerosis and vascular dysfunction. Antioxidants may inhibit atherogenesis and improve vascular function by two different mechanisms. First, lipid-soluble antioxidants present in low-density lipoprotein (LDL), including
-tocopherol, and water-soluble antioxidants present in the extracellular fluid of the arterial wall, including ascorbic acid (vitamin C), inhibit LDL oxidation through an LDL-specific antioxidant action. Second, antioxidants present in the cells of the vascular wall decrease cellular production and release of reactive oxygen species (ROS), inhibit endothelial activation (i.e., expression of adhesion molecules and monocyte chemoattractants), and improve the biologic activity of endothelium-derived nitric oxide (EDNO) through a cell- or tissue-specific antioxidant action.
-Tocopherol and a number of thiol antioxidants have been shown to decrease adhesion molecule expression and monocyte-endothelial interactions. Vitamin C has been demonstrated to potentiate EDNO activity and normalize vascular function in patients with coronary artery disease and associated risk factors, including hypercholesterolemia, hyperhomocysteinemia, hypertension, diabetes, and smoking.
This article has been cited by other articles:
![]() |
G. P. Van Guilder, G. L. Hoetzer, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza Acute and chronic effects of vitamin C on endothelial fibrinolytic function in overweight and obese adult humans J. Physiol., July 15, 2008; 586(14): 3525 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. KC, J. M. Carcamo, and D. W. Golde Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury FASEB J, October 1, 2005; 19(12): 1657 - 1667. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Yermolaieva, R. Xu, C. Schinstock, N. Brot, H. Weissbach, S. H. Heinemann, and T. Hoshi Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation PNAS, February 3, 2004; 101(5): 1159 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Abiko, A. Abiko, A. C. Clermont, B. Shoelson, N. Horio, J. Takahashi, A. P. Adamis, G. L. King, and S.-E. Bursell Characterization of Retinal Leukostasis and Hemodynamics in Insulin Resistance and Diabetes: Role of Oxidants and Protein Kinase-C Activation Diabetes, March 1, 2003; 52(3): 829 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toth, Z. Kukor, and S. Valent Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity Mol. Hum. Reprod., March 1, 2002; 8(3): 271 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Bell, S. I. Mosfer, D. Lang, F. Donaldson, and M. J. Lewis Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1704 - H1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. N. Das Exploring the actions of vitamin C. Can. Med. Assoc. J., July 10, 2001; 165(1): 13 - 14. [Full Text] |
||||
![]() |
G. Paolisso, D. Manzella, M. R. Tagliamonte, M. Barbieri, R. Marfella, G. Zito, M. Bonafè, D. Giugliano, C. Franceschi, and M. Varricchio The BB-Paraoxonase Genotype Is Associated with Impaired Brachial Reactivity after Acute Hypertriglyceridemia in Healthy Subjects J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1078 - 1082. [Abstract] [Full Text] |
||||
![]() |
A. Azzi, I. Breyer, M. Feher, R. Ricciarelli, A. Stocker, S. Zimmer, and J.-M. Zingg Nonantioxidant Functions of {{alpha}}-Tocopherol in Smooth Muscle Cells J. Nutr., February 1, 2001; 131(2): 378S - 381. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |